Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115403505B details novel thioester synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN117164506B details palladium catalyzed carbonylation for indeno indole one. Efficient route ensures cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation route offers high yields and substrate tolerance for drug molecule synthesis like Rutaecarpine.
Patent CN102659662A details a mild base-catalyzed synthesis of 3-hydroxy-2-oxindoles from isatin, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Novel catalytic method using p-nitrobenzoic acid offers cost-effective synthesis of beta-amino esters with high regioselectivity for reliable API manufacturing.
Novel Ag2O-promoted cycloaddition patent CN113735778B enables cost-effective production. Reliable supplier for high-purity imidazole intermediates with scalable processes.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN114920775B details novel axial chiral bisindole catalyst synthesis offering high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel synthesis method for axial chiral indole pyrrole-furan compounds with high enantioselectivity and yield, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115286578B reveals metal-free room temperature synthesis reducing cost and enhancing supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel CuCl catalyzed route for high-purity intermediates. Cost effective scale-up. Reliable supply chain for global pharmaceutical manufacturing partners seeking efficiency.
Patent CN105418710B reveals a cost-effective route for 2,6-Dichloropurine Nucleoside. Enhance supply chain reliability with scalable pharmaceutical intermediates.
Patent CN118878452B reveals novel antitumor compound synthesis. Offers mild conditions and high yield for pharmaceutical intermediate supply chains. Enables cost reduction in API manufacturing.
Novel Pd-catalyzed multicomponent route for indolinone-imidazole scaffolds. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Patent CN117164544A reveals a novel palladium-catalyzed method for pyrone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN119161318A reveals mild Pd-catalyzed route for benzopyran amides. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel copper-catalyzed synthesis offers high yield and cytotoxic activity for pharmaceutical intermediates supply chain optimization.
Patent CN113735826A reveals a novel Pd-catalyzed carbonylation route for 3-benzylidene-2,3-dihydroquinolones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110511221A reveals efficient Rh-catalyzed synthesis for imidazopyridines. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Delivers high stereoselectivity and supply chain reliability for pharmaceutical manufacturing.